| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.32e-05 | 188 | 61 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | NAD+-protein-aspartate ADP-ribosyltransferase activity | 9.13e-05 | 5 | 61 | 2 | GO:0140806 | |
| GeneOntologyMolecularFunction | calcium ion binding | 4.23e-04 | 749 | 61 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.97e-04 | 120 | 61 | 4 | GO:0004222 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.66e-05 | 530 | 65 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.86e-04 | 656 | 65 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.90e-04 | 658 | 65 | 9 | GO:0030312 | |
| Domain | EGF-like_dom | JAG2 SLIT2 FRAS1 EYS HMCN1 WIF1 LAMB1 EGFL8 ADAM8 ADAM12 PEAR1 | 6.34e-10 | 249 | 63 | 11 | IPR000742 |
| Domain | EGF_1 | JAG2 SLIT2 EYS HMCN1 WIF1 LAMB1 EGFL8 ADAM8 ADAM12 SSPOP PEAR1 | 8.15e-10 | 255 | 63 | 11 | PS00022 |
| Domain | EGF_2 | JAG2 SLIT2 EYS HMCN1 WIF1 LAMB1 EGFL8 ADAM8 ADAM12 SSPOP PEAR1 | 1.22e-09 | 265 | 63 | 11 | PS01186 |
| Domain | EGF_3 | 5.86e-09 | 235 | 63 | 10 | PS50026 | |
| Domain | EGF | 5.86e-09 | 235 | 63 | 10 | SM00181 | |
| Domain | EGF-like_CS | 1.59e-08 | 261 | 63 | 10 | IPR013032 | |
| Domain | EMI | 2.71e-07 | 17 | 63 | 4 | PS51041 | |
| Domain | ACR | 1.95e-06 | 27 | 63 | 4 | SM00608 | |
| Domain | ADAM_Cys-rich | 1.95e-06 | 27 | 63 | 4 | IPR006586 | |
| Domain | TSP_1 | 2.25e-06 | 63 | 63 | 5 | PF00090 | |
| Domain | hEGF | 2.26e-06 | 28 | 63 | 4 | PF12661 | |
| Domain | TSP1 | 2.63e-06 | 65 | 63 | 5 | SM00209 | |
| Domain | TSP1_rpt | 2.63e-06 | 65 | 63 | 5 | IPR000884 | |
| Domain | TSP1 | 2.63e-06 | 65 | 63 | 5 | PS50092 | |
| Domain | EGF | 4.15e-06 | 126 | 63 | 6 | PF00008 | |
| Domain | VWFC_1 | 6.38e-06 | 36 | 63 | 4 | PS01208 | |
| Domain | VWC | 7.96e-06 | 38 | 63 | 4 | SM00214 | |
| Domain | VWFC_2 | 7.96e-06 | 38 | 63 | 4 | PS50184 | |
| Domain | Peptidase_M12B_N | 8.85e-06 | 39 | 63 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 8.85e-06 | 39 | 63 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 9.81e-06 | 40 | 63 | 4 | PS00427 | |
| Domain | Reprolysin | 9.81e-06 | 40 | 63 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 9.81e-06 | 40 | 63 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 9.81e-06 | 40 | 63 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 9.81e-06 | 40 | 63 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 1.08e-05 | 41 | 63 | 4 | IPR001762 | |
| Domain | VWF_dom | 1.19e-05 | 42 | 63 | 4 | IPR001007 | |
| Domain | Growth_fac_rcpt_ | 1.41e-05 | 156 | 63 | 6 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 1.89e-05 | 97 | 63 | 5 | IPR018097 | |
| Domain | EMI_domain | 1.99e-05 | 16 | 63 | 3 | IPR011489 | |
| Domain | EGF_CA | 2.08e-05 | 99 | 63 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.19e-05 | 100 | 63 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.90e-05 | 106 | 63 | 5 | IPR000152 | |
| Domain | VWC_out | 3.41e-05 | 19 | 63 | 3 | SM00215 | |
| Domain | EGF_extracell | 4.97e-05 | 60 | 63 | 4 | IPR013111 | |
| Domain | EGF_2 | 4.97e-05 | 60 | 63 | 4 | PF07974 | |
| Domain | EGF_CA | 5.69e-05 | 122 | 63 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.15e-05 | 124 | 63 | 5 | IPR001881 | |
| Domain | MetalloPept_cat_dom | 1.61e-04 | 81 | 63 | 4 | IPR024079 | |
| Domain | - | 1.61e-04 | 81 | 63 | 4 | 3.40.390.10 | |
| Domain | TLV_coat | 2.33e-04 | 7 | 63 | 2 | PF00429 | |
| Domain | TLV/ENV_coat_polyprotein | 3.09e-04 | 8 | 63 | 2 | IPR018154 | |
| Domain | ZINC_PROTEASE | 3.35e-04 | 98 | 63 | 4 | PS00142 | |
| Domain | EMI | 4.95e-04 | 10 | 63 | 2 | PF07546 | |
| Domain | Laminin_G_1 | 6.04e-04 | 11 | 63 | 2 | PF00054 | |
| Domain | Disintegrin_CS | 1.30e-03 | 16 | 63 | 2 | IPR018358 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 1.47e-03 | 17 | 63 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 1.47e-03 | 17 | 63 | 2 | PS51059 | |
| Domain | PARP | 1.47e-03 | 17 | 63 | 2 | PF00644 | |
| Domain | - | 1.47e-03 | 17 | 63 | 2 | 3.90.228.10 | |
| Domain | CTCK_1 | 1.65e-03 | 18 | 63 | 2 | PS01185 | |
| Domain | ADAM_CR | 1.65e-03 | 18 | 63 | 2 | PF08516 | |
| Domain | - | 2.05e-03 | 20 | 63 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 2.26e-03 | 21 | 63 | 2 | PF00200 | |
| Domain | DISIN | 2.26e-03 | 21 | 63 | 2 | SM00050 | |
| Domain | ADAM_spacer1 | 2.71e-03 | 23 | 63 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.71e-03 | 23 | 63 | 2 | PF05986 | |
| Domain | WGR_domain | 2.95e-03 | 24 | 63 | 2 | IPR008893 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.95e-03 | 24 | 63 | 2 | IPR013273 | |
| Domain | EGF_CA | 3.07e-03 | 86 | 63 | 3 | PF07645 | |
| Domain | Ricin_B_lectin | 3.20e-03 | 25 | 63 | 2 | PF00652 | |
| Domain | Cys_knot_C | 3.20e-03 | 25 | 63 | 2 | IPR006207 | |
| Domain | CTCK_2 | 3.20e-03 | 25 | 63 | 2 | PS01225 | |
| Domain | Galactose-bd-like | 3.94e-03 | 94 | 63 | 3 | IPR008979 | |
| Domain | RICIN | 4.00e-03 | 28 | 63 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 4.00e-03 | 28 | 63 | 2 | PS50231 | |
| Domain | Ricin_B_lectin | 4.58e-03 | 30 | 63 | 2 | IPR000772 | |
| Domain | Glycos_transf_2 | 4.58e-03 | 30 | 63 | 2 | PF00535 | |
| Domain | Glyco_trans_2-like | 4.58e-03 | 30 | 63 | 2 | IPR001173 | |
| Domain | Laminin_EGF | 6.20e-03 | 35 | 63 | 2 | PF00053 | |
| Domain | EGF_Lam | 6.20e-03 | 35 | 63 | 2 | SM00180 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.18e-06 | 109 | 53 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.53e-06 | 111 | 53 | 6 | M27416 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.40e-06 | 68 | 53 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.33e-05 | 39 | 53 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.33e-05 | 39 | 53 | 4 | MM15165 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.23e-04 | 300 | 53 | 7 | M610 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.94e-04 | 143 | 53 | 5 | M27275 | |
| Pathway | REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES | 3.56e-04 | 37 | 53 | 3 | M27244 | |
| Pubmed | 1.36e-07 | 64 | 65 | 5 | 22261194 | ||
| Pubmed | 3.04e-07 | 75 | 65 | 5 | 20637190 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 6.26e-07 | 36 | 65 | 4 | 25615642 | |
| Pubmed | EYS IL22RA2 EPHA6 ADAMTS4 NOX5 ZDHHC9 WIF1 UGT3A2 CSMD1 EGFL8 ADAM12 | 1.97e-06 | 985 | 65 | 11 | 12975309 | |
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 3.44e-06 | 2 | 65 | 2 | 27890662 | |
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 3.44e-06 | 2 | 65 | 2 | 21439553 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 3.44e-06 | 2 | 65 | 2 | 24408017 | |
| Pubmed | Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin. | 3.44e-06 | 2 | 65 | 2 | 29437589 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 23555306 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 18826608 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 12906867 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 22315090 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 17606262 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 19135121 | ||
| Pubmed | FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation. | 2.06e-05 | 4 | 65 | 2 | 15574124 | |
| Pubmed | 2.44e-05 | 30 | 65 | 3 | 19054571 | ||
| Pubmed | ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. | 3.43e-05 | 5 | 65 | 2 | 17072319 | |
| Pubmed | 5.13e-05 | 6 | 65 | 2 | 23085571 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 20660068 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 15907280 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 33504453 | ||
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 17344430 | ||
| Pubmed | 1.14e-04 | 407 | 65 | 6 | 12693553 | ||
| Pubmed | 1.15e-04 | 50 | 65 | 3 | 23658023 | ||
| Pubmed | 2.13e-04 | 156 | 65 | 4 | 22008794 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 26813283 | ||
| Pubmed | Expression of peroxiredoxins and thioredoxins in the mouse spinal cord during embryonic development. | 2.65e-04 | 13 | 65 | 2 | 25975898 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 22993228 | ||
| Pubmed | 2.76e-04 | 167 | 65 | 4 | 22159717 | ||
| Pubmed | 3.30e-04 | 175 | 65 | 4 | 28071719 | ||
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 18303054 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 30579834 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 23153495 | ||
| Pubmed | Family-wide analysis of poly(ADP-ribose) polymerase activity. | 4.06e-04 | 16 | 65 | 2 | 25043379 | |
| Pubmed | 5.16e-04 | 18 | 65 | 2 | 38266827 | ||
| Pubmed | 5.16e-04 | 18 | 65 | 2 | 23534349 | ||
| Pubmed | 5.16e-04 | 18 | 65 | 2 | 14730302 | ||
| Pubmed | 5.52e-04 | 85 | 65 | 3 | 15449545 | ||
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 6.39e-04 | 20 | 65 | 2 | 29961574 | |
| Pubmed | 6.39e-04 | 20 | 65 | 2 | 19922873 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 6.73e-04 | 91 | 65 | 3 | 28558017 | |
| Pubmed | Changes in gene-expression during development of the murine molar tooth germ. | 7.06e-04 | 21 | 65 | 2 | 17374359 | |
| Pubmed | 7.76e-04 | 22 | 65 | 2 | 23850713 | ||
| Pubmed | 7.76e-04 | 22 | 65 | 2 | 25107907 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 8.85e-04 | 100 | 65 | 3 | 25807483 | |
| Pubmed | 9.24e-04 | 24 | 65 | 2 | 31740596 | ||
| Pubmed | 9.24e-04 | 24 | 65 | 2 | 31882545 | ||
| Pubmed | 9.24e-04 | 24 | 65 | 2 | 25825872 | ||
| Pubmed | 9.24e-04 | 24 | 65 | 2 | 17676665 | ||
| Pubmed | 1.08e-03 | 622 | 65 | 6 | 14574404 | ||
| Pubmed | BMP receptor 1b is required for axon guidance and cell survival in the developing retina. | 1.17e-03 | 27 | 65 | 2 | 12654290 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.21e-03 | 248 | 65 | 4 | 24006456 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 1.26e-03 | 28 | 65 | 2 | 27002738 | |
| Pubmed | 1.26e-03 | 28 | 65 | 2 | 18617019 | ||
| Pubmed | 1.35e-03 | 29 | 65 | 2 | 22613833 | ||
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 1.53e-03 | 121 | 65 | 3 | 31900314 | |
| Pubmed | Zbtb20 is essential for the specification of CA1 field identity in the developing hippocampus. | 1.65e-03 | 32 | 65 | 2 | 20308569 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.74e-03 | 1201 | 65 | 8 | 35696571 | |
| Pubmed | 1.75e-03 | 33 | 65 | 2 | 34841685 | ||
| Pubmed | The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airways. | 1.75e-03 | 33 | 65 | 2 | 23213461 | |
| Pubmed | 1.80e-03 | 128 | 65 | 3 | 23858473 | ||
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 7.01e-04 | 17 | 42 | 2 | 684 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 8.79e-04 | 19 | 42 | 2 | 50 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 9.75e-04 | 20 | 42 | 2 | 433 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.78e-03 | 27 | 42 | 2 | 47 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 7.75e-03 | 57 | 42 | 2 | 1179 | |
| Coexpression | NABA_MATRISOME | SLIT2 P4HA2 FRAS1 EYS HMCN1 ADAMTS4 WIF1 EMILIN2 VWC2L LAMB1 ADAMTS8 EGFL8 ADAM8 ADAM12 SSPOP PLXNB1 | 2.89e-09 | 1026 | 65 | 16 | M5889 |
| Coexpression | NABA_MATRISOME | SLIT2 P4HA2 FRAS1 HMCN1 ADAMTS4 WIF1 EMILIN2 VWC2L LAMB1 ADAMTS8 EGFL8 ADAM8 ADAM12 SSPOP PLXNB1 | 1.84e-08 | 1008 | 65 | 15 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.67e-07 | 196 | 65 | 7 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 5.37e-06 | 275 | 65 | 7 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.00e-06 | 191 | 65 | 6 | MM17059 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 5.38e-05 | 268 | 65 | 6 | M45796 | |
| Coexpression | NABA_CORE_MATRISOME | 5.61e-05 | 270 | 65 | 6 | MM17057 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 8.27e-05 | 738 | 65 | 9 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 9.45e-05 | 751 | 65 | 9 | M5885 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3 | 1.91e-05 | 377 | 65 | 8 | GSM476681_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 184 | 66 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 184 | 66 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-08 | 184 | 66 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 8.15e-08 | 146 | 66 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.35e-07 | 159 | 66 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 174 | 66 | 6 | 1c073177c1753e3b91ef8fd9e95230a1d13c82f3 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-07 | 174 | 66 | 6 | 5491ad5c144baf2ef9b1c58eb720c872d14feb15 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.51e-07 | 187 | 66 | 6 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-07 | 192 | 66 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.23e-07 | 193 | 66 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.74e-06 | 148 | 66 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | PND07-28-samps-Lymphocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.65e-06 | 157 | 66 | 5 | 105f2711d7bae3be36714954e103c61cf021f957 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 161 | 66 | 5 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 161 | 66 | 5 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 164 | 66 | 5 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 165 | 66 | 5 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 165 | 66 | 5 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-06 | 173 | 66 | 5 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-06 | 173 | 66 | 5 | 3678b300cad4effd7f49bfb043305ed512693848 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 174 | 66 | 5 | aae7ab9df5a78716034ddfd5bd47adc69912d624 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 174 | 66 | 5 | d9489c4196d103ead8cb6279492bbe563a222e45 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-06 | 175 | 66 | 5 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-06 | 177 | 66 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.55e-06 | 177 | 66 | 5 | 8b003ed7887479c3a010ef37dd981b748256bda7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.55e-06 | 177 | 66 | 5 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.55e-06 | 177 | 66 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.73e-06 | 178 | 66 | 5 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.92e-06 | 179 | 66 | 5 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.11e-06 | 180 | 66 | 5 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.11e-06 | 180 | 66 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-06 | 180 | 66 | 5 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-06 | 180 | 66 | 5 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.11e-06 | 180 | 66 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.30e-06 | 181 | 66 | 5 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.70e-06 | 183 | 66 | 5 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.70e-06 | 183 | 66 | 5 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.70e-06 | 183 | 66 | 5 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 184 | 66 | 5 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 184 | 66 | 5 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-06 | 184 | 66 | 5 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.12e-06 | 185 | 66 | 5 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.34e-06 | 186 | 66 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.55e-06 | 187 | 66 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.78e-06 | 188 | 66 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.78e-06 | 188 | 66 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 8.78e-06 | 188 | 66 | 5 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 189 | 66 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.24e-06 | 190 | 66 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.24e-06 | 190 | 66 | 5 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.24e-06 | 190 | 66 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.48e-06 | 191 | 66 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.48e-06 | 191 | 66 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.72e-06 | 192 | 66 | 5 | dc4b4e16e6eb212e45fb70695afd1c7e91027407 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.72e-06 | 192 | 66 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 9.72e-06 | 192 | 66 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 9.97e-06 | 193 | 66 | 5 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-05 | 194 | 66 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.02e-05 | 194 | 66 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.02e-05 | 194 | 66 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 194 | 66 | 5 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-05 | 194 | 66 | 5 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 195 | 66 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 196 | 66 | 5 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-05 | 196 | 66 | 5 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 197 | 66 | 5 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 197 | 66 | 5 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 197 | 66 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.10e-05 | 197 | 66 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.10e-05 | 197 | 66 | 5 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 197 | 66 | 5 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.10e-05 | 197 | 66 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 66 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-05 | 199 | 66 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.16e-05 | 199 | 66 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3---L2-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 9c89e91bb630cc306a820927a36ea6fb3d13e9d7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.18e-05 | 200 | 66 | 5 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-05 | 200 | 66 | 5 | a6500d0d2e8bcac92381ab771dbdee66b0e1d48e | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK---L2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 6ebdae4438bc64c6620416f64a7e22fbca2664bf | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.18e-05 | 200 | 66 | 5 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 081ca331b56f85167acfc73af9d2e91f398f8c4d | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 8821574d17b55dfea3ca0204e6b4c0ca6b19588a | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 66e2f3e2e9063f17b47621120eb6009405f69e7e | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 0f23e72649a274043bf23e0952a9b5707c516acf | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 96b1d2e70fbbba744fd4356a70efcf356aca9abc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 66 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-FREM3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | ad6f1d4d7f5d7bab2ba2e4fff58c535290065c0e | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | 940892bea41fde567f138a896d151acccef03a6a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.18e-05 | 200 | 66 | 5 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-05 | 200 | 66 | 5 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.43e-05 | 132 | 66 | 4 | dc6edfa821a1cdc645668b0af5ba5ff80dee10bd | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.43e-05 | 132 | 66 | 4 | 60ced08bda5efc95a6f116cd0c6d1a779d99ed38 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.84e-05 | 135 | 66 | 4 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells-T_cells_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.27e-05 | 138 | 66 | 4 | 221a964e86d7d3406cdb7573899155fee8d33abd | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.42e-05 | 139 | 66 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.56e-05 | 146 | 66 | 4 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 4.47e-05 | 5 | 63 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | brain volume measurement | 2.72e-04 | 595 | 63 | 7 | EFO_0006930 | |
| Disease | glycerate measurement | 4.63e-04 | 15 | 63 | 2 | EFO_0021029 | |
| Disease | colorectal health | 9.09e-04 | 201 | 63 | 4 | EFO_0008460 | |
| Disease | brain measurement, neuroimaging measurement | 1.13e-03 | 550 | 63 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | obesity (implicated_via_orthology) | 1.17e-03 | 215 | 63 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | lumbar disc degeneration | 1.64e-03 | 28 | 63 | 2 | EFO_0004994 | |
| Disease | brain connectivity measurement | 1.65e-03 | 400 | 63 | 5 | EFO_0005210 | |
| Disease | hair morphology | 1.76e-03 | 29 | 63 | 2 | EFO_0005038 | |
| Disease | pyridoxate measurement | 2.00e-03 | 31 | 63 | 2 | EFO_0010527 | |
| Disease | uridine measurement | 2.14e-03 | 32 | 63 | 2 | EFO_0010546 | |
| Disease | loneliness measurement | 2.39e-03 | 124 | 63 | 3 | EFO_0007865 | |
| Disease | cortical thickness | 2.46e-03 | 1113 | 63 | 8 | EFO_0004840 | |
| Disease | coronary aneurysm | 2.55e-03 | 35 | 63 | 2 | EFO_1000881 | |
| Disease | mood instability measurement | 2.62e-03 | 128 | 63 | 3 | EFO_0008475 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.67e-03 | 447 | 63 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | sleep latency | 2.85e-03 | 37 | 63 | 2 | EFO_0005280 | |
| Disease | unipolar depression, mood disorder | 2.98e-03 | 134 | 63 | 3 | EFO_0003761, EFO_0004247 | |
| Disease | phosphatidylcholine 32:1 measurement | 3.00e-03 | 38 | 63 | 2 | EFO_0010373 | |
| Disease | multiple system atrophy | 3.32e-03 | 40 | 63 | 2 | EFO_1001050 | |
| Disease | Congenital small ears | 3.49e-03 | 41 | 63 | 2 | C0152423 | |
| Disease | Thromboembolism | 4.01e-03 | 44 | 63 | 2 | HP_0001907 | |
| Disease | nasopharyngeal neoplasm | 4.17e-03 | 151 | 63 | 3 | EFO_0004252 | |
| Disease | platelet aggregation | 4.19e-03 | 45 | 63 | 2 | GO_0070527 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.25e-03 | 152 | 63 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | homocysteine measurement | 4.37e-03 | 46 | 63 | 2 | EFO_0004578 | |
| Disease | intraocular pressure measurement | 4.63e-03 | 509 | 63 | 5 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLCEWVVKGQPAHCV | 276 | Q6ZTR7 | |
| QTHAVCCQGWKKRHP | 91 | Q99944 | |
| LQGPHCAAVNAVAWC | 586 | Q8NAA4 | |
| SIKDHPWHIQSCCAL | 146 | Q96KC2 | |
| NHQWNHALPSCDALC | 916 | Q96PZ7 | |
| CQQDHHWSGKTPFCV | 2756 | Q7Z408 | |
| WCHTDGAEPLCHTKN | 476 | Q9UP79 | |
| INHRQCDQCKHGWVA | 51 | Q01954 | |
| FCPHQKLSQCHELWE | 341 | P06127 | |
| NNRKNCHCEAHWAPP | 671 | O43184 | |
| AGCHPNLTHWCPAKQ | 156 | B6SEH9 | |
| GVCNHKQECHCHAGW | 621 | P78325 | |
| TIHTNKCICLLSHWP | 306 | Q7Z401 | |
| QKARHCGHCPEEWIT | 111 | P26715 | |
| CPWLQQQHKGSVEAC | 1511 | Q14573 | |
| KHTCPSCQHSWIEGV | 611 | Q96PH1 | |
| TGSNHRCPTLQHIWK | 346 | Q9Y6F1 | |
| PTKLLQNGWCVHSCG | 441 | Q86XX4 | |
| KCQPGWSGHHCENEL | 1186 | Q5T1H1 | |
| RHGKNIENCHVPWCA | 2326 | Q5T1H1 | |
| PGWKGINCHINVNDC | 451 | Q9Y219 | |
| LCQDWFHGQCVSVPH | 1191 | Q9BY66 | |
| AGCHPNLTHWCPAKQ | 156 | B6SEH8 | |
| WQHLCTHKASCDAGP | 656 | O43157 | |
| WAGLHCNESCPQDTH | 386 | Q5VY43 | |
| QIHQGKIPACVHRSW | 686 | Q6ZU69 | |
| QIHQGKIPACVHRSW | 416 | Q63HN1 | |
| TGQHCDQCLPEHWGL | 486 | P07942 | |
| HQKPSGCWQHISCNF | 76 | Q969J5 | |
| HSLWHLQIPVDCQAC | 71 | Q86SH4 | |
| VCNERNCPIHGKWAT | 4691 | Q96RW7 | |
| HFCHLAWVNTPKKQG | 81 | Q06830 | |
| HAACPVLVGCKWVSN | 501 | O15460 | |
| NHGECKRPWPQHQCS | 521 | Q8WY54 | |
| HCLLCNNKTHWAPVR | 561 | Q5T6X5 | |
| PCAALWCSGHLNGHA | 466 | O75173 | |
| GPCQVIVHKWETHLQ | 81 | Q9NPB8 | |
| WQCGGKLEIHPCSHV | 346 | Q8N4A0 | |
| KQGCWSHIGDPQECH | 81 | Q13873 | |
| QWKGTCRQQTALHCP | 36 | Q6ZV80 | |
| GLHCVWCQITLHNKC | 336 | Q9Y6T7 | |
| IWQCGGVLETHPCSH | 346 | Q8IXK2 | |
| HPVAHCCSQLEERWQ | 661 | Q9BXX0 | |
| GHTARVNCIQWICKQ | 56 | Q6IA86 | |
| CHLKGWQHRPTQHNA | 166 | P51172 | |
| VHLNHNPWHCNCDVL | 306 | Q9NT99 | |
| QKHGNIWVCPVSDHV | 576 | Q2NL67 | |
| CPASLHQLMLHCWQK | 901 | Q9UF33 | |
| AKLCNAVQHCQKHVW | 496 | Q6NUJ1 | |
| QHPEPGWHCQVVACV | 1296 | A2VEC9 | |
| ENGHCVPHGWLCDNQ | 1386 | A2VEC9 | |
| LHVPLRQHQVSCCDW | 166 | O15056 | |
| QTCPWSHGLNLHLCI | 76 | Q8TCY5 | |
| QLLHPWCQVNVGSCR | 896 | Q12769 | |
| VVVDFHAQWCGPCKI | 81 | Q99757 | |
| DHHCPWVGNCVGKRN | 166 | Q9Y397 | |
| QFAEWICHLHKQPCH | 291 | P42285 | |
| CWPLLCGAHVCQKNS | 101 | Q8IV04 | |
| HEPNKCQCQEGWHGR | 321 | Q9Y5W5 | |
| HNLSEPCIQGCHFWN | 51 | P08922 | |
| HLAQNPFICDCHLKW | 426 | O94813 | |
| NICHCHNGDWWKPAQ | 196 | B2RUY7 | |
| AWRCPHCKQLQQGSI | 616 | Q70CQ4 | |
| CHHVVKGLFVWCQGC | 746 | Q96S15 | |
| SAWGLCIHENCHDPQ | 491 | Q9C0I4 | |
| AHLPQGVIWKCQCSH | 321 | Q3SY77 | |
| CQCSHWPKDVHLAAN | 331 | Q3SY77 | |
| NWPSCHCLISFHSKG | 101 | Q6PFW1 | |
| AAHLGCWQKVDPALC | 351 | Q9GZU3 | |
| WNPIHCQHIECHNAI | 301 | Q9P2D8 | |
| KWCPQNTQYCLTVHH | 81 | Q8NI32 |